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ABSTRACT	  	  
The	   innate	   immune	  system	   is	  vital	   to	   rapidly	   responding	   to	  pathogens	  and	  Toll-­‐like	   receptors	  
(TLRs)	   are	   a	   critical	   component	   of	   this	   response.	   Nanovesicular	   exosomes	   play	   a	   role	   in	  
immunity,	   but	   to	   date	   their	   exact	   contribution	   to	   the	   dissemination	   of	   the	   TLR	   response	   is	  
unknown.	  Here	  we	  show	  that	  exosomes	  from	  TLR	  stimulated	  cells	  (TLR-­‐exosomes)	  can	   largely	  
recapitulate	   TLR	   activation	   in	   distal	   cells	   in	   vitro.	   We	   can	   abrogate	   the	   action-­‐at-­‐a-­‐distance	  
signaling	   of	   exosomes	   by	  UV	   irradiation,	   demonstrating	   that	   RNA	   is	   crucial	   for	   their	   effector	  
function.	  We	  are	  the	  first	  to	  show	  that	  exosomes	  derived	  from	  poly(I:C)	  stimulated	  cells	  induce	  
in	   vivo	   macrophage	   M1-­‐like	   polarization	   within	   murine	   lymph	   nodes.	   These	   TLR-­‐exosomes	  
demonstrate	   enhanced	   trafficking	   to	   the	   node	   and	   preferentially	   recruit	   neutrophils	   as	  
compared	   to	   control-­‐exosomes.	   This	   work	   definitively	   establishes	   the	   differential	   effector	  
function	  for	  TLR-­‐exosomes	  in	  communicating	  the	  activation	  state	  of	  the	  cell	  of	  origin.	  
	  
	  
	  
	  
	  
	  
	  
Introduction	  
Detecting microbial pathogens rapidly and containing their spread is a critical function of the 
innate immune system (1). Toll-like receptors (TLR) are an essential arm of innate immunity as 
they detect highly conserved pathogen associated molecular patterns (PAMPs) and play an 
important role in host cell defense  (2). The direct response of cells stimulated TLR agonists 
locally is well characterized (3, 4). Dendritic cells when exposed to the TLR4 agonist 
lipopolysaccharide (LPS) show a distinct gene expression response as compared with cells 
exposed to the TLR3 agonist poly I:C (pIC), and these gene expression profiles are known to be 
pathogen specific (5). TLR stimulation induces production of a broad range of molecules 
including cytokines and chemokines (6), which are essential for host response to infection as 
well as for the development of an adaptive immune response (7).  
While cytokines and chemokines are well studied for their roles in mediating cell-cell 
communication to establish immunity (8), recently more complex messengers such as 
extracellular vesicles have been discovered (9). Exosomes are nanovesicles (30-150nm in 
diameter) released by the fusion of large multivesicular endosomes with the host cell membrane 
(10) . They are released by most known cell types, ubiquitously found  in biological fluids (11) 
and carry functional cargo in the form of mRNA, miRNA and proteins to distal recipient cells 
where the contents can modulate the recipient cell phenotype (12). 
Exosomes have many distinct roles in physiology and immunity (13-15) and have known to play 
dual roles in both immune system activation (16) and immune suppression (17). Furthermore, we 
recently showed that exosomes are rapidly trafficked from peripheral tissues by the lymphatics, 
and retained in the draining lymph node by macrophages in a murine model (18). 
While local cellular response to TLR stimulation is well studied both in vitro and in vivo (19-21), 
the role of exosomes in the distal dissemination of the TLR response is less well understood. We 
speculated that exosomes from TLR stimulated cells could potentially transmit information to 
distal unexposed cells in vitro. Moreover, we wanted to understand the impact of stable 
lymphatic retention of exosomes by macrophages in the development of an immune response in 
vivo.  
Here we delineate the differential effector function of exosomes based on the innate immune 
activation state (control-, LPS-, poly(I:C)-stimulation) of the cell of origin in both in vitro and in 
vivo experiments. Poly(I:C) derived exosomes are rapidly transported to the lymph node and 
polarize distal macrophages to an M1-like state and recruit neutrophils. We show that exosomes 
are reprogrammed to carry a TLR-specific message to distal cells and more work is warranted to 
understand the implications of this in immunity to pathogens and cancer. 
Results	  
Characterization	  of	  exosomes	  	  
To understand the effect of exosomal cargo released from locally stimulated cells on distal cell 
expression, we collected exosomes from local ovarian adenocarcinoma (HEY) cells that were 
either unstimulated (control exosomes), or stimulated with poly(I:C) (pIC exosomes), or 
lipopolysaccharide (LPS exosomes) for 48 hours. The three groups of exosomes were added to 
naïve (distal) cells and the changes in gene expression profiles were compared between local 
TLR stimulation (for 6 hours) and distal stimulation mediated by exosomes (for 48 hours) on a 
microarray (Fig. 1a).  
Figure	  1:	  Experimental	  setup,	  biophysical	  and	  biochemical	  characterization	  of	  exosomes.	  (a):	  Schematic	  
showing	   experimental	   setup	  where	   local	   cells	   are	   either	   unstimulated	   or	   directly	   stimulated	  with	   TLR	  
agonists	  LPS	  and	  poly(I:C)	  for	  6	  hours.	  Exosomes	  are	  collected	  from	  the	  local	  cells	  and	  exposed	  to	  distal	  
cells	  for	  24	  hours	  and	  then	  both	  local	  and	  distal	  cells	  are	  profiled	  by	  microarrays	  (b)	  Expression	  of	  CD81	  
and	   CD63	   on	   the	   surface	   of	   control,	   pIC	   and	   LPS	   exosomes	   as	   quantified	   by	   flow	   cytometry	   (c)	   Size	  
distribution	  profiles	  of	  control,	  pIC	  and	  LPS	  exosomes	  quantified	  on	  a	  Zetasizer	  (d)	  Western	  blot	  of	  CD81	  
protein	   expression	   on	   control,	   pIC	   and	   LPS	   exosomes.	   Scanning	   electron	   micrographs	   of	   (e)	   Control	  
exosomes,	   (f)	   pIC	   exosomes	   and	   (g)	   LPS	   exosomes	   showing	   characteristic	   spherical	   shape.	   Scale	   bars,	  
500	  nm.	  Confocal	   images	  of	  distal	  cells	  showing	  uptake	  of	  PKH67	  labeled	  (h)	  Control	  exosomes,	  (i)	  pIC	  
exosomes	  and	  (j)	  LPS	  exosomes.	  Scale	  bars,	  10	  µm.	  	  
Nanovesicular exosomes were obtained through ultracentrifugation as described previously (18) 
and were found to have the canonical exosomal tetraspanins CD81 and CD63. We found 
comparable surface CD81 protein expression by western blot across the control, pIC and LPS 
exosomes (Fig. 1b, Supplementary Fig. 1a) and flow cytometry showed comparable levels of 
expression of CD81 and CD63 on control, pIC and LPS exosomes (Fig. 1c, Supplementary Fig. 
1 b-c).  The size distribution profiles were similar for the three groups (Fig. 1d) and we noted 
that control-, pIC- and LPS-exosomes was spherical, as revealed by scanning electron 
micrographs (Fig. 1 e-g respectively). Finally, the uptake of control-, pIC- and LPS-exosomes 
by distal cells was comparable (Fig. 1 h-j). Therefore, the three groups of exosomes did not 
differ in biophysical and biochemical properties or cellular uptake.  
Effect	  of	  LPS	  on	  local	  and	  distal	  cells	  
We analyzed microarray data to identify genes that were differentially expressed in i) local and 
ii) distal cells with respect to unstimulated cells. Our findings indicate that local cells stimulated 
with LPS as well as distal cells stimulated with LPS-exosomes both show enhanced expression 
of key inflammatory genes (Fig. 2a). The classical LPS response occurs via binding to TLR4 
which results in activation of an inflammatory response and release of TNFA, CCL3 and IL1B.  
The cell then enters a refractory state resistant to further LPS stimulation characterized by 
increased TOLLIP expression and NF-κB inactivation (22) (Fig. 2b).  
 Figure	  2:	  The	  LPS	  response	  in	  local	  and	  distal	  cells.	  (a)	  Heatmap	  of	  selected	  inflammatory	  genes	  involved	  
in	  LPS	  response	  in	  local	  and	  distal	  cells.	  (b)	  Classical	  LPS	  response	  pathway	  showing	  the	  key	  genes	  and	  
inhibitors	   that	  establish	   the	   initial	   inflammatory	  phase	  and	  the	  subsequent	   refractory	  phase.	   (c)	  Distal	  
cell	   gene	  expression	   after	   exposure	   to	   either	   LPS	  exosomes	  or	  UV	   irradiated	   LPS	  exosomes	   (24	  hours	  
post	  exosome	  addition).	  (d)	  Time	  course	  of	  gene	  expression	  comparing	  local	  cell	  response	  to	  LPS	  (solid	  
line)	  against	  distal	  cell	   response	  to	  LPS	  exosomes	  (dotted	   line)	   for	  the	  genes	  shown.	  Proximity	   ligation	  
assay	   showing	   (e)	  NF-­‐κB	   activation	   state	   in	   distal	   cells	  with	   LPS	   exosome	   stimulation	   as	  measured	   by	  
colocalization	   of	   p50-­‐p65	   subunits,	   (f)	   SIRT1	  mediated	   inactivation	   of	   NF-­‐κB	   after	   restimulating	   distal	  
cells	  with	  1	  hour	  of	  LPS	  as	  measured	  by	  colocalization	  of	  NF-­‐κB	  subunit	  p65	  with	  SIRT1	  colocalization	  and	  
(g)	  inactivation	  of	  NF-­‐κB	  by	  pretreating	  LPS	  exosomes	  with	  UV.	  Scale	  bars,	  20µm.	  	  
	  
Exposure to LPS exosomes caused distal cells to upregulate molecular pathways associated with 
chemokine signaling as well as TLR activation (Supplementary Fig. 4a). To examine the 
temporal response of local cells to LPS and distal cells to LPS-exosomes we evaluated changes 
in gene expression with respect to control cells using qRT-PCR (Fig. 2d). We looked at CCL3, 
IL1B, TNFA, TIRAP, TRAF6 and TOLLIP expression over 48 hours and observed that peak local 
cell response to LPS stimulation was at 6 hours with TOLLIP expression peaking at 12 hours. 
Distal cells responded to LPS-exosome stimulation at 24 hours to levels comparable with local 
cells. 
Previous studies have utilized UV light to degrade the RNA payload of exosomes, and we see 
similar UV-based elimination of exosomal RNA as detected by chip-based electrophoresis.  
(Supplementary Fig. 5 a-c). Distal cells exposed to UV treated LPS-exosomes showed 
significantly decreased expression of the six gene panel as compared with LPS-exosomes, and 
recapitulated the response of cells exposed to control-exosomes. This indicates that UV 
irradiation, likely through degradation of RNA, was necessary and sufficient to modulate the 
effector function of exosomes in distal cells (Fig. 2c).  
LPS-exosomes contained ~4% carryover of initial LPS dose (Supplementary Fig. 2a). We 
exposed local cells to this carryover dose and examined gene expression at 6h, 12h and 24h time 
points (Supplementary Fig. 2c,d) which shows limited contribution to distal response. 
A proximity ligation assay (PLA) was used to determine the co-localization of the p50 and p65 
subunits of NF-κB to indicate activation of this complex. Local cells exposed to LPS and distal 
cells treated LPS exosomes showed co-localization of p50 and p65 subunits indicating that the 
NF-κB complex was active in both (Supplementary Fig. 3a, Fig. 2e). 
Endotoxin tolerance is a protective mechanism to prevent overt inflammation in response to LPS 
and results in a transient unresponsive cellular state, characterized by the epigenetic inactivation 
of the p65 subunit of NF-κB by the histone deacetylase SIRT1 (23).  Local and distal cell 
response to LPS re-stimulation, and resulting impact on NF-κB silencing state, was analyzed 
using PLA (Supplementary Fig. 3b). We exposed distal cells to LPS-exosomes and then re-
stimulated them with LPS and we found that these cells had hallmarks of endotoxin tolerance 
with p65-SIRT1 co-localization resulting in NF-κB inactivation (Fig. 2f). Additionally, UV 
irradiation of exosomes abrogated i) NF-κB activation and ii) SIRT1 mediated inactivation in 
distal cells (Fig. 2g). 
Effect	  of	  pIC	  on	  local	  and	  distal	  cells	  
We analyzed microarray data to detect genes involved in i) local pIC and ii) distal pIC-exosomes 
responses as compared with unstimulated cells, in particular with respect to genes involved in 
antiviral activity (Fig. 3a). The classical pIC response occurs via endosomally localized TLR3 
binding pIC, or cytoplasmic MDA5 resulting in NF-κB activation and interferon production2 
(Fig. 3b). 
 Figure	  3:	  The	  pIC	  response	  in	  local	  and	  distal	  cells.	  (a)	  Heatmap	  of	  selected	  antiviral	  genes	  involved	  in	  
viral	  RNA	  response	  in	  local	  and	  distal	  cells.	  (b)	  Pathways	  of	  intracellular	  response	  to	  pIC	  showing	  both	  
the	  cytoplasmic	  recognition	  pathway	  on	  the	  left	  and	  the	  endosomal	  pathway	  on	  the	  right.	  (c)	  Scatter	  
plots	  showing	  the	  correlation	  between	  the	  fold	  change	  detected	  via	  qPCR	  when	  compared	  to	  
microarrays	  (d)	  Time	  course	  of	  gene	  expression	  comparing	  local	  cell	  response	  to	  pIC	  (solid	  lines)	  against	  
distal	  cell	  response	  to	  pIC	  exosomes	  (dotted	  lines)	  for	  the	  genes	  shown.	  (e)	  Distal	  cell	  gene	  expression	  
after	  exposure	  to	  either	  pIC	  exosomes	  or	  UV	  irradiated	  pIC	  exosomes	  (24	  hours	  post	  exosome	  addition).	  
Verifying	  NF-­‐κB	  activation	  in	  (f)	  local	  cells	  with	  pIC,	  (g)	  distal	  cells	  with	  pIC	  exosomes	  or	  (h)	  distal	  cells	  
with	  UV	  treated	  pIC	  exosomes	  confirming	  the	  colocalization	  of	  P50-­‐P65	  subunits	  using	  a	  proximity	  
ligation	  assay.	  Scale	  bars,	  50	  µm.	  	  
Distal cells exposed to pIC-exosomes were found to upregulate the following pathways: 
TLR/RXR activation and RIG-1 like receptor (Supplementary Fig. 4b). To examine the 
temporal response of local and distal cells to pIC/pIC-exosomes, respectively, we evaluated 
changes in gene expression using qRT-PCR (Fig. 3d). Analyzing IRF1, MAVS, IFN, STAT1 and 
TRAF6 gene expression over 48 hours we observed that local cells responded to pIC stimulation 
between 6-12 hours, and that distal cells responded to pIC-exosome stimulation between 12-24 
hours at comparable levels. Additionally, we found high concordance between local and distal 
cell gene expression using both microarrays and qRT-PCR (Fig. 3c).  
We could not detect any carryover of pIC to distal cells by pIC-exosomes (Supplementary Fig. 
2b). Distal gene expression after exposure to UV-irradiated pIC-exosomes showed a complete 
abrogation of changes in gene expression as detected by qRT-PCR (Fig. 3e). Exposing local cells 
to pIC and distal cells exposed to pIC-exosomes lead to NF-κB activation as detected by PLA 
signal of the active P50-P65 heterodimer (Fig. 3f, g respectively), which was abrogated by UV-
irradiation of pIC-exosomes (Fig. 3h).  
Effect	  of	  exosome	  uptake	  on	  macrophages	  
To understand the impact of exosome uptake on macrophage function in vivo, mice were injected 
with either PBS, control-exosomes or pIC-exosomes. We verified the uptake of control- and pIC-
exosomes by macrophages in murine lymph nodes using co-localization of fluorescently labeled 
exosomes and CD11b (Supplementary Fig. 7). Lymph nodes were extracted at 48 hours post 
injection followed by isolation CD11b macrophages and subsequent analysis by RNA-Seq. 
Whole lymph nodes were sectioned to verify protein expression by immunohistochemistry (Fig. 
4a). 
 Figure	  4:	  	  Effect	  of	  exosome	  uptake	  on	  macrophages.	  (a)	  Schematic	  showing	  mouse	  study	  with	  injection	  
of	   either	   PBS,	   control-­‐,	   or	   pIC-­‐exosomes	   locally	   followed	   by	   excision	   of	   distal	   draining	   lymph	   nodes,	  
isolation	  of	  macrophages	  and	  analysis	  of	  macrophage	  gene	  expression	  by	  next	  generation	  sequencing.	  
(b)	   Relative	   expression	   of	   key	   M1	   and	   housekeeping	   genes	   in	   macrophages	   after	   exposure	   to	   PBS,	  
control-­‐	  or	  pIC-­‐exosomes.	  (c)	  Validation	  of	  key	  M1	  genes	  in	  macrophages	  with	  control-­‐	  or	  pIC-­‐exosomes	  
as	  compared	  to	  PBS	  by	  qRT-­‐PCR.	  (d)	  Validation	  of	  M1	  markers	  Nos2	  and	  Il12	  expression	  in	  lymph	  node	  
sections	  after	  exposure	  to	  control-­‐	  or	  pIC-­‐exosomes.	  White	  scale	  bars,	  50	  μm,	  yellow	  scale	  bars,	  10	  μm. 
The relative gene expression of macrophages with PBS, control- and pIC-exosomes is depicted 
for selected genes (Fig. 4b). pIC-exosomes strongly polarize the macrophages to an M1 like state 
with a significant shift in gene expression, while control exosomes show an intermediate 
phenotype (Fig. 4b). Macrophages with pIC-exosomes in vivo show an enrichment of pro-
inflammatory pathways including NF-κB signaling and Chemokine signaling pathways 
(Supplementary Fig. 6a). A complete list of genes enriched in pIC-exosomes with respect to 
PBS and control exosomes is provided (Supplementary Table 3-4). 
The gene expression of M1 markers was validated using qRT-PCR (Fig. 4c). We find that 
macrophages from mice with pIC-exosome injection had a significantly higher expression of all 
the selected M1 markers when compared to control-exosomes (Fig. 4c). The correlation between 
macrophage gene expression with PBS, control- or pIC-exosomes determined by RNA-Seq and 
validation by qRT-PCR was high (Supplementary Fig. 6b).  Whole lymph node sections with 
pIC exosomes showed high expression of Il12, Nos2, Cd86, and MhcII, while sections with 
control-exosomes showed low to no expression of the same markers (Fig. 4d, Supplementary 
Fig. 8)  
Impact	  of	  lymphatic	  trafficking	  of	  exosomes	  on	  draining	  lymph	  
node	  retention	  
To investigate differences in lymphatic transport of control- and pIC-exosomes, mice tails were 
imaged using the NIR system described previously18. We observed that the kinetics of transport 
of pIC exosomes in both the dominant and non-dominant vessel was considerably higher than 
that of control-exosomes in both lymphatic vessels (Fig. 5a, Supplementary Fig. 9a-h). 
Similarly, pIC-exosomes were retained to a much higher extent in the draining lymph nodes as 
compared to control-exosomes, a difference that can be seen as early as five minutes after 
intradermal injection (Fig. 5b, Supplementary Fig. 9i-l). The transport times and packet 
frequencies of control- and pIC-exosomes were not significantly different in the vessels or lymph 
nodes (Supplementary Fig. 10). The total packet transport, which is a measure of the indicative 
of total pump flow that takes into account both the amplitude of lymphatic contraction and the 
frequency of pumping, is significantly higher for pIC-exosomes than control exosomes Taken 
together, this data suggests that exosomes released from pIC stimulated cells enhance lymph 
flow and the subsequent retention of exosomes at the lymph node (Fig. 5c).  
 
 
 Fig.	   5:	   Impact	   of	   lymphatic	   trafficking	   of	   exosomes	   on	   draining	   lymph	   node	   retention	   (a)	   Kinetics	   of	  
lymphatic	   vessel	   transport	   comparing	   control	   and	   pIC	   exosome	   trafficking	   in	   the	   dominant	   and	   non-­‐
dominant	   vessels.	   (b)	   Comparison	   of	   kinetics	   of	   draining	   lymph	   node	   retention	   of	   control	   and	   pIC	  
exosomes	   in	   dominant	   and	   non-­‐dominant	   nodes.	   (c)	   Lymphatic	   packet	   transport	   of	   control	   and	   pIC	  
exosomes.	  (d)	  Schematic	  of	  experiment	  showing	  PBS,	  control	  or	  pIC	  exosomes	  in	  mouse	  tail,	  followed	  by	  
lymph	  node	  extraction	   at	   48	  hours	   followed	  by	  RNA-­‐Seq	  of	  whole	   lymph	  nodes.	   (e)	   Pathway	   analysis	  
showing	   pathways	   enriched	   in	   pIC	   exosomes	   in	   whole	   nodes	   with	   respect	   to	   PBS	   and	   (f)	   Relative	  
expression	   of	   key	   neutrophil	   markers	   in	   whole	   lymph	   nodes	   after	   exposure	   to	   PBS,	   control	   or	   pIC	  
exosomes.	  (g)	  Validation	  of	  neutrophil	  recruitment	  and	  inflammation	  in	  the	  whole	  node	  with	  control	  or	  
pIC	  exosomes	  as	  compared	  to	  PBS	  by	  qPCR.	  
 
To understand the impact of exosome retention on the lymph node in vivo, the lymph nodes were 
extracted at 48 hours post exosome injection and analyzed by RNA-Seq (Fig. 5d, 
Supplementary Table 5). Pathway analysis of whole nodes comparing pIC-exosomes with PBS 
shows an increase in pro-inflammatory signaling pathways (Fig. 5e). We extracted the gene 
expression of the 546 genes utilized to estimate the abundance of 22 immune subsets based on 
the CIBERSORT algorithm, extending the algorithm to utilize our RNA-Seq data (24). Using 
this analysis we found evidence of neutrophil, mast cell and monocyte recruitment in the pIC-
exosomes group as compared to the PBS and control-exosome groups. The relative gene 
expression of whole nodes with PBS, control- and pIC-exosomes for selected neutrophil markers 
is shown in Fig. 5f. The gene expression of neutrophil recruitment markers and inflammatory 
signals in the whole node was validated using qRT-PCR (Fig. 5g). We find that whole lyph 
nodes from mice with pIC-exosome injection had a significantly higher expression of all the 
selected genes when compared to control-exosomes (Fig. 5g) 
Whole lymph node sections with pIC exosomes showed high expression of Gr1 and Ly6g while 
sections with control-exosomes showed low to no expression of the same markers (Fig. 6a-b). 
 Figure	   6:	   Validation	   of	   neutrophil	   recruitment	   to	   node.	   A)	   Immunohistochemistry	   of	   lymph	   node	  
sections	   showing	   increase	   of	   neutrophil	  markers	   after	   pIC	   exosome	  uptake	  A)	  GR1	   expression	   and	  B)	  
Ly6G	   expression	   after	   control	   and	   pIC	   exosome	   uptake.	   	   C)	   Model	   of	   exosome	   action	   showing	  
transmittance	  of	  local	  cell	  TLR	  activation	  to	  distal	  cells	  resulting	  in	  a	  pro-­‐inflammatory	  response	  both	  in	  
vitro	  and	  in	  vivo.	  
Finally, our model for exosome mediated cell-cell communication in the dissemination of the 
TLR response is shown (Fig. 6c). We have shown that both LPS- and pIC-exosomes elicit a pro-
inflammatory or antiviral gene response in vitro that is characterized by the activation and 
localization of NF-κB in the nucleus. Furthermore, exosomes are taken up by macrophages and 
polarized to a M1-like pro-inflammatory state characterized by the increased expression of Il12 
and Nos2 while the node is reprogrammed to recruit neutrophils and shows increased 
inflammation. 
Discussion	  
The ability of the immune system to recognize and respond to foreign organisms is essential 
to survival and TLR’s play a central role in this response (6). Exosomes have many distinct roles 
that vary depending on their cell of origin, from modulating the immune response(13), to cancer 
progression and immune evasion (14). Here, for the first time we show that distal target cells are 
primed to respond to imminent pathogen attack via TLR mediated NF-κB activation and the 
resulting secretion of pro-inflammatory cytokines.  
Our experiments demonstrate reproducible perturbations of distal cells with minimal to 
nonexistent agonist carryover demonstrating the importance of the immune state of the cell of 
origin. We observe a ~12-18 hour shift in distal cell response likely corresponding to the time 
required for exosome uptake, unpacking and release of contained biomolecules within the distal 
cells. Similar timing has been noted for luciferase mRNA delivery and subsequent expression 
within a glioblastoma exosome delivery model (25). Additionally, exosomal RNA was able to 
recapitulate the inflammation and apoptosis in cells post M. tuberculosis infection (26) We, like 
others before us, suggest that RNA is likely the key contributor to the effects observed since the 
relative dose of UV light in this experiment completely degrades RNA but has minimal potential 
to degrade/inactivate protein (27, 28).  
The discovery of pathogen derived components from infected cells and the subsequent effect 
on immune activation is well studied (29). Here we show recapitulation of infection response via 
exosomes from TLR stimulated cells underscoring the contribution of the host cell to the 
pathogen response. Furthermore, we provide a model to delineate the contribution of the host and 
pathogen to the response elicited in distal cells post exosomes exposure.  
We also show that exosomes derived from TLR stimulated cells epigenetically modify distal 
cells to be refractory to further LPS stimulation (i.e. undergo endotoxin tolerance), thus 
protecting these distal cells from uncontrolled inflammation (23). While the TLR response and 
endotoxin tolerance is well characterized in immune cells, it is less understood in non-immune 
cells (2). To our knowledge this is the first study to demonstrate that exosomes from non-
immune cell origin can i) epigenetically modify and ii) convey TLR-specific information to 
downstream cells. Further studies are needed to understand the contribution of exosomes from 
non-immune cells to the innate and adaptive immune response. 
The biological importance of exosomes in the crosstalk between cancer cells and the immune 
subsets is a growing area of research. Ovarian cancer is associated with one of the highest 
mortalities (30) and survival statistics have not improved significantly over the past three (31), 
highlighting the need to better understand the tumor microenvironment. Inflammation is a 
hallmark of in situ tumors and has important implications for cancer cell survival, proliferation 
and migration (32). TLR activation of the tumor microenvironment impacts tumor growth 
kinetics (33-35), and actively contributes to inflammation and tumor derived exosomes likely 
disseminate this information impacting cancer fate.  
Administration of pIC in mouse models of melanoma, lung cancer and colon cancer elicited 
robust anti-tumor immune responses (36) and our present work suggests that pIC-exosomes 
derived from the site of pIC injection could be playing a role in this response. Researchers would 
be wise to consider the potential role of TLR-exosomes and their potential to impact on diverse 
cancer immunotherapy regiments. 
Subcapsular sinus (SCS) macrophages play roles in suppressing the spread of melanoma thus 
enhancing immunity (37). We previously showed an important role for SCS macrophages in 
exosome retention (18) that we expand to demonstrate that ovarian cancer-derived exosomes are 
capable of inducing an inflammatory response via Il12 and Nos2 in murine macrophages in vivo. 
Nos2 results in nitric oxide (NO) production by macrophages contributing to diverse mechanisms 
including cytotoxic activity against viruses and bacteria (38), reduction in lymphatic contractions 
(39) and inhibition of ovarian cancer growth (40).  
 The ability of pIC-exosomes to rapidly modulate lymphatic function within minutes of 
injection, to increase transport and nodal retention is striking considering that careful attention 
was taken to ensure total exosome dose, total fluorescence, and total injected volume were the 
same between all measurement groups. Collecting lymphatics vessels are known to exhibit fast 
functional responses to their environment (41) through direct mechanical or biological stimuli. 
Thus the response observed here could be the result of the direct interaction of exosomes with 
lymphatics, interactions with the immune cells that reside within the lymphatic wall (42) or 
through an indirect effect of the exosomes at the injection site on lymph formation.  or through 
an indirect effect of the exosomes at the injection site on lymph formation.  Furthermore, the 
enhanced NO signaling seen in lymph node resident immune cells 48 hours later, suggests that 
exosomes could continue flow modulation via immune cell mediated NO release, as has been 
shown in other inflammatory models (39). The data shown here is the first evidence that 
exosomes could directly be involved in modulating flow to the lymph node, a significant finding 
since the enhanced lymphatic function also leads to enhanced uptake of the exosomes within the 
cells of the draining lymph node. Given the reliance of exosomes and immune cell trafficking on 
lymphatic transport, the impact of exosome-mediated flow modulation, either through NO 
secretion by macrophages or some other unidentified mechanism, on the subsequent immune 
response warrants further study.  
Neutrophils release cytokines and chemokines to coordinate the innate and adaptive immune 
responses and play active roles in antigen presentation (43). We saw an enrichment of neutrophil 
recruitment signals including FPR1 and CXCR2 (44) in the whole node accompanied with an 
increase in pro-inflammatory cytokines, such as IL1B. Thus, the lymph node microenvironment 
is being reprogrammed by exosomes to respond to the signals sent by the parent cells. 
The ability of exosomes to carry siRNA, drugs, proteins and other molecules makes them 
ideal therapeutic vehicles (45). Several promising clinical trials for exosome based therapeutics 
were unable to get reproducible results in patients and we show that minor perturbations to the 
biological state of the cell of origin can contribute to exosome effector function. We show that 
TLR-exosomes have distinct and rapid kinetics, and that they can deliver fundamental innate 
immune signals faithfully. We show that UV irradiation can fundamentally reset the effector 
signal of pIC exosomes to control-exosomes, but it is not clear if this will reset the kinetics of 
lymph node transfer. Our work points out the potential of TLR-exosomes for therapeutic use, but 
it is also a cautionary tale of the how exosomes kinetics and effector function are a definite 
product of the physiological state of the cell of origin.  
Materials	  and	  methods	  
Cell	  culture	  and	  TLR	  stimulation	  	  
Fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA) was centrifuged for 15 hours at 
120,000 g, 4OC to remove exosomes and was used to make exosome free cell culture media. 
HEY cells (Cedarlane Labs, Ontario, Canada) were cultured in RPMI 1640 (Mediatech, 
Manassas, VA) supplemented with 10% exosome free fetal bovine serum, 2 mM L-glutamine, 10 
mM HEPES buffer (both from Mediatech), penicillin (100 U/ml), and streptomycin (100 µg/mL) 
(Thermo Fisher Scientific, Waltham, MA) for 48 hours and the culture media was used for 
isolation of exosomes by ultracentrifugation. Ultra-pure E.coli K12 LPS and poly(I:C) ( 
Invivogen, San Diego, CA) were used to treat cells at concentrations of 100 ng/mL and 10 
µg/mL  respectively for most experiments. Fluorescent LPS- Alexa Fluor 594 (Thermo Fisher 
Scientific) and poly(I:C) Rhodamine (Invivogen) were used at the same concentration to 
determine exosome mediated carryover.  
Exosome	  isolation	  and	  characterization	  
Conditioned media was collected from HEY cells (with or without TLR agonist treatment) at 
90% confluence for exosome isolation. Briefly, the culture media was spun at 300 g, for 10 
minutes to remove dead cells followed by a spin at 16,500 g, 20 min. The supernatant was then 
filtered through 0.22 µm filters and centrifuged at 120,000 g for 120 min. The pellet containing 
exosomes was re-suspended in a suitable volume of PBS. The size homogeneity of vesicles 
obtained was checked using a Zetasizer Nano ZS90 (Malvern Instruments Ltd,	  Worcestershire, 
UK) and quantified using Pierce BCA Protein assay kit (Thermo Fisher Scientific). 
Flow	  Cytometry	  
To analyze the expression of exosomal surface markers, 4 µm aldehyde/sulfate latex beads 
(Thermo Fisher Scientific) were coated with anti-CD9 antibody (BD Biosciences, San Diego, 
CA; Cat: 555370) overnight and incubated with 30 μg of exosomes. The exosome-beads 
complexes were probed with Anti Human CD81-PE (BD Biosciences; Cat: 555676)  or Anti 
human CD63-PE (BD Biosciences; Cat: 557305) and data was acquired on a LSR II Flow 
cytometer (BD Biosciences). Data analysis was performed using the FloJo software (FlowJo 
version 10, Ashland, OR).  
Confocal	  microscopy	  
The exosomes were labeled using PKH67 Green Fluorescent Cell Linker Kit for General Cell 
Membrane Labeling (Sigma-Aldrich, St. Louis, MO) as per the manufacturer’s instructions. 
Briefly, exosomes in PBS were added to 500 µL of Diluent C and 2 µl of PKH67 dye was added 
to 500 µL of Diluent C. The two solutions were mixed and incubated for 5 min at room 
temperature. 1 ml of 1% BSA was added to stop the reaction. The labeled exosomes were 
centrifuged at 120,000 g for 70 min to remove excess dye. Labeled exosomes were added to 
5*105 cell suspension, mixed gently for 2-3 min and seeded in 6-well plates. The cells were 
imaged after 24 and 48 hours using a Zeiss LSM 700 Image processing and data analysis were 
performed using the ZEN imaging software (Zeiss, Germany). 
Scanning	  electron	  microscopy	  
Exosomes were fixed with 3.7% glutaraldehyde (Sigma–Aldrich) on carbon stubs for 15 min. 
After washing twice with PBS, the fixed exosomes were dehydrated with an ascending sequence 
of ethanol (40%, 60%, 80%, 96–98%). After evaporation of ethanol, the samples were left to dry 
at room temperature for 24 h on a glass substrate, and then analyzed by	   Hitachi Cold Field 
Emission SEM SU8200 (Hitachi High-Tec, Tokyo, Japan).  
UV	  treatment	  of	  exosomes	  
Exosomes from control, and TLR agonist stimulated cells were re-suspended in PBS were then 
subjected to UV-light (254 nm) for 30 mins at 4°C to neutralize RNA carried within similar to 
previous studies(28).  
Nucleic	  acid	  extraction	  from	  exosomes	  
Exosomal RNA was extracted from exosome samples using the QIAamp viral RNA mini kit 
(Qiagen), and RNA was eluted with 40 µL buffer AVE, according to the manufacturer's 
instructions. RNA quality and quantity was analyzed using Nanodrop and Agilent Bioanalyzer 
chips 
Western	  blot	  
The total protein was extracted from cells and exosomes using modified RIPA buffer (Thermo 
Fisher Scientific) and cell debris was removed by centrifugation. Equal amounts of protein (15–
20 µg) were then separated on polyacrylamide gels, transferred onto PVDF membranes (Bio-
Rad, Hercules, CA, USA) and blotted using mouse anti-human CD81 Antibody (BD 
Biosciences; Cat: 555676).  Membranes were developed using SuperSignal™ West Dura 
Extended Duration Substrate (Thermo Fisher Scientific).  
Microarray	  procedure	  and	  data	  analysis	  	  
Total RNA was isolated from control and TLR stimulated parental and recipient cells (grown 
with exosomes) after 48 hours using RNeasy mini RNA isolation kit (QIAGEN, Valencia, CA). 
The integrity of the RNA was verified using the Agilent 2100 Bioanalyzer (Agilent 
Technologies, Santa Clara, CA). mRNA’s were converted to double stranded DNA and 
amplified using the Applause 3’-Amp System (NuGen, San Carlos, CA). This cDNA was 
fragmented and biotin labeled using the Encode Biotin Module (NuGen), hybridized to 
Affymetrix HG U133 Plus 2.0  oligonucleotide arrays and analyzed with a Gene Chip Scanner 
3000 (Affymetrix, Santa Clara, CA). Raw data in the form of CEL files were produced by the 
Affymetrix GeneChip Operating System (GCOS) software. 
mRNA microarray data were analyzed using the Expression Console software (Affymetrix) and 
Bioconductor tools(46) written in the R statistical programming language (www.rproject.org). 
Pre-processing of raw signal intensities and normalization was performed using GCRMA (R). 
Linear modelling of the transformed data was determined by using Limma(47) in R with the 
Benjamini and Hochberg correction. Differentially expressed probesets were identified using a 
threshold 5% FDR correction and a fold change ≥ 1.4 was applied. The microarray data has been 
uploaded to GEO (Gene Expression Omnibus, accession number GSE81248)  
Real-­‐time	  quantitative	  PCR	  (qRT-­‐PCR)	  	  
Parental HEY cells were grown with or without LPS or poly(I:C) stimulation and total RNA 
from the cells was collected at 2h, 6h, 12h , 24h or 48 hours.  Similarly, control, LPS or 
poly(I:C) exosomes were added to recipient cells and total RNA was collected from cells grown 
with exosomes at 2h, 6h, 12h, 24h and 48 hours respectively. Total RNA from macrophages as 
well as parental and recipient cells was extracted using an RNeasy plus kit (QIAGEN), and 
cDNA was generated with SuperScript VILO cDNA Synthesis Kit (Thermo Fisher Scientific). 
Analysis was done on a Strategene Mx3005P System (Agilent Technologies) with SYBR Green 
PCR master Mix (Thermo Fisher Scientific). The (intron spanning) primers were used for 
quantitative real-time PCR are shown in Supplementary Tables 1 and 2.  The fold change was 
calculated using the ΔΔCt method. All analyses were run in Prism 6 (GraphPad Software Inc, La 
Jolla, CA) and all data is presented as mean ± standard deviation.	  
Proximity	  Ligation	  Assay	  (PLA)	  
HEY cells were cultured on 12-mm glass cell culture coverslips (Thermo Fisher Scientific).  
Cells were washed three times with phosphate-buffered saline (PBS) and then fixed for 15 min in 
PBS with 4% paraformaldehyde. After washing with gentle shaking, cells were permeabilized 
for 5 min with methanol and washed. The proximal-ligation assay to detect the interaction of p50 
with p65, anti-	  NF-κB p50 (Santa Cruz Biotech, Dallas, TX; Cat: sc-8414) and anti-NF-κB p65 
(Santa Cruz; Cat: sc-372) and for p65- SIRT1 interaction, anti-NF-κB p65(Santa Cruz Biotech; 
Cat: sc-8008) and anti-SIRT1 (Santa Cruz; Cat: sc-15404) were used with a Duolink PLA assay 
kit (Sigma Aldrich). Images were acquired Zeiss LSM 700 (Zeiss). 
Animal	  study	  and	  handling	  
Exosomes from unstimulated (Control) and poly I:C stimulated HEY cells were dual labeled 
with PKH67 and near infrared dye using IRDye® 800CW Protein labeling kit (Licor, Lincoln, 
NE). Control or Poly I:C exosomes (total quantity=10 μg) were injected intradermally into the 
tail of eight-week-old male Balb/C mice (Charles River Laboratories, Wilmington, MA) as 
described previously(18) and euthanized on day two( t=48 hours). PBS was mixed with 
PEGylated IRdye 800CW (Licor) and injected similarly as the experimental control. The LAL 
Chromogenic Endotoxin Quantitation Kit (Thermo Fisher Scientific) was used per the 
manufacturer’s instruction to measure LPS concentration on all injected exosomes to ensure no 
endotoxin crossover. All procedures in this study have been approved by the Georgia Institute of 
Technology IACUC Review Board (Protocol #A15051).  
Lymph	  node	  extraction	  and	  macrophage	  isolation	  
The draining (sacral) lymph nodes, and control (axillary) lymph nodes were harvested from 
Control exosomes [Group 1; n=10], poly I:C exosomes[Group 2; n=10] and PBS control [Group 
3; n=8]. Harvested lymph nodes from all groups were digested with collagenase D (Roche Ltd., 
Mannhein, Germany) and homogenized using 70 µm pore size strainers as previously 
described(48). Cells were centrifuged at 300 g, 4OC, 5 mins and the pellet was resuspended in 
HBSS and used for either whole node sequencing or macrophage isolation. CD11b positive 
macrophages were pulled down with Anti-mouse CD11b magnetic particles (BD Biosciences; 
Cat: 558013) according to the manufacturer’s protocol. The isolated macrophages were 
resuspended in Trizol (Thermo Fisher Scientific) and stored at -80oC till further analysis. 
Immunohistochemistry	  of	  frozen	  lymph	  node	  sections	  
One set of lymph nodes (both sacral and axillary) from both groups were snap-frozen in Tissue-
Tek OCT (VWR, Radnor, PA) and sectioned at the Winship Cancer Institute’s Pathology Core. 
Frozen sections of excised sacral and axillary nodes were blocked in 10% BSA in PBS and 
incubated with primary antibody overnight, and then secondary antibody for 2 h. Primary 
antibodies were anti-CD86 (Cat: MA1-10299), anti-iNOS(Cat: PA3-030A),  anti-MHCII (Cat: 
MA5-16913) [all 3 from Thermo Fisher Scientific] and anti-IL12A (Acris Antibodies, San 
Diego, CA; Cat: AM32704AF-N). These sections were detected using secondary antibodies 
conjugated with Alexa Fluor 647 or Alexa 680 (Thermo Fisher Scientific) and imaged by 
confocal microscopy using a Zeiss LSM 700. 
RNA	  Seq:	  Macrophage	  and	  whole	  node	  RNA	  isolation	  and	  library	  prep	  
RNA was isolated from macrophages or digested whole nodes stored in Trizol (ThermoFisher 
Scientific) per the manufacturer’s instructions. Briefly, macrophages from control exosomes 
(n=2), pIC exosomes (n=2) and PBS dye (n=2) were homogenized for 20–30  sec with a rotor-
stator homogenizer (Kimble Chase, Vineland, NJ).	  The sample lysates were then transferred to 
2.0  ml Phase Lock Gels – Heavy (Eppendorf, Hamburg, Germany). Choloroform was added to 
each sample and centrifuged at 12,000  rcf for 10 min, and the upper aqueous layer was 
transferred to a new tube. The RNA was precipitated in isopropanol and washed in 75% ethanol 
according to the standard TRIzol protocol. The RNA pellet was then resuspended in RNase-free 
water (Ambion, Austin, TX) according to the manufacturer's instructions. RNA quantity and 
integrity were assessed by examining the relative intensity of 18s and 28s rRNA bands using an 
Agilent 2100 Bioanalyzer and RNA6000 Pico LabChip Kit (Agilent Technologies).  
10 ng of Macrophage RNA was used as input to a Clontech Smart Seq v4 kit (Clontech labs, 
Mountain View, CA) to generate double stranded cDNA per the manufacturer’s instructions. The 
cDNA was quantified using the Qubit HS DNA kit (Thermo Fisher Scientific) and 1 ng was used 
to prepare libraries using a Nextera XT DNA library preparation kit (Illumina, San Diego, CA) 
per the manufacturer’s instructions.  
250 ng of whole node RNA was used as input in a Truseq Stranded mRNA library prep kit 
(Illumina) to generate cDNA libraries. Both libraries were quantified using a Qubit Fluorimeter 
(Thermo Fisher Scientific) and multiplexed samples were run on a HiSeq 2500 instrument 
(Illumina). Each library was sequenced for 2×40 million of 100-nucleotide reads. 
Data	  analysis	  
RNA seq analysis for the three conditions, each with two replicates, was performed using raw 
reads (101bp, paired end) from an Illumina HiSeq 2000 machine. The reads were first aligned to 
the mouse reference genome (mm10, UCSC), using TopHat with default parameters. The 
transcripts were assembled from the aligned reads using Cufflinks, and the transcript abundance 
was calculated in terms of FPKM (fragments per kilobase of exon per million fragments 
mapped)(49). To compare the expression profile of the different samples, we used Cuffdiff, a 
differential expression analysis tool provided with the Cufflinks package. The results from 
Cuffdiff were used to plot the gene expression distribution graphs using a custom R script  
The pathway analysis was performed using the GAGE RNA Seq workflow for pathway 
enrichment analysis(50). The –Log10(P-value) of the pathways of interest was plotted in R.  
Details of the analysis and the custom R scripts used to generate the figures are publicly 
available at the Github web site https://github.com/shashidhar22/macrophageRnaSeq. The data is 
publicly accessible in Sequence read archive (SRA) under the accession numbers: SRP074717 
and SRP074576. 
All graphs were generated on Prism 6 (GraphPad Software Inc, La Jolla, CA) and data is 
presented as mean  ±  standard deviation.	  
Near	  infrared	  image	  analysis	  
Mice were imaged in the Near-infrared system and all transport metrics were calculated as 
previously described(18).	  Packet	  transport	  was	  calculated	  by	  integrating	  the	  fluorescence	  signal	  under	  
the	  curve	  of	  each	  intensity	  spike.	  These	  intensity	  spikes	  have	  recently	  been	  shown	  to	  directly	  correlate	  
with	  reductions	  in	  lymphatic	  diameter	  due	  to	  intrinsic	  lymphatic	  pumping(51).	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Figure	  S1:	  Characterization	  of	  exosomes	  used	  in	  the	  study.	  (a)	  Complete	  western	  blot	  of	  CD81	  with	  
control,	  pIC	  and	  LPS	  exosomes.	  Flow	  cytometry	  showing	  (b)	  CD63	  and	  (c)	  CD81	  levels	  on	  the	  exosomes.	  
	  
	  Figure	  S2:	  Estimating	  the	  carryover	  of	  TLR	  agonist	  from	  local	  cells	  to	  distal	  cells	  by	  exosomes.	  Confocal	  
images	  showing	  (a)	  LPS-­‐AF594	  and	  pIC-­‐	  Rhodamine	  uptake	  by	  parental	  cells	  and	  (b)	  exosomes	  from	  local	  
cells	  treated	  with	  LPS-­‐AF594	  and	  pIC-­‐	  Rhodamine	  added	  to	  distal	  cells	  to	  show	  no	  PIC	  and	  4%	  LPS	  
carryover.	  Scale	  bars,	  50	  μm.	  (c)	  Time	  course	  of	  gene	  expression	  in	  local	  cells	  after	  stimulation	  with	  4%	  
LPS	  and	  (d)	  Comparison	  of	  gene	  expression	  at	  24	  hours	  between	  local	  cells	  stimulated	  with	  4%	  LPS	  and	  
distal	  cells	  stimulated	  with	  LPS	  exosomes.	  
	  Figure	  S3:	  	  The	  LPS	  response	  in	  local	  and	  distal	  cells.	  Proximity	  ligation	  assay	  showing	  (a)	  the	  P50-­‐P65	  co-­‐
localization	  and	  (b)	  P65-­‐SIRT1	  in	  the	  cells	  indicated	  
	  Figure	  S4:	  Pathways	  analysis	  of	  distal	  cells	  from	  microarray	  data.	  Pathways	  enriched	  in	  distal	  cells	  
stimulated	  with	  (a)	  LPS	  exosomes	  and	  (b)	  pIC	  exosomes	  	  
	  
Figure	  S5:	  	  Effect	  of	  UV	  on	  nucleic	  acid	  content	  of	  exosomes.	  RNA	  size	  distribution	  profiles	  obtained	  on	  a	  
Bioanalyzer	  pico	  RNA	  chip	  of	  (a)	  Control	  exosomes	  ,	  (b)	  pIC	  exosomes,	  	  and	  (c)	  LPS	  exosomes	  ;	  before	  
(red	  lines)	  and	  after	  UV	  treatment	  (blue	  Line)	  	  
	  Figure	  S6:	  	  RNA-­‐Seq	  of	  distal	  macrophages.	  (a)	  Pathways	  enriched	  in	  distal	  macropages	  with	  pIC	  
exosomes	  as	  compared	  to	  PBS.	  (b)	  Scatter	  plots	  showing	  the	  correlation	  between	  the	  fold	  change	  
detected	  via	  qCR	  when	  compared	  to	  RNA-­‐Seq	  
	  Figure	  S7:	  	  Macrophages	  retain	  both	  control	  and	  pIC	  exosomes	  (a)	  CD11b+	  macrophages	  and	  (b)	  CD169+	  
subcapsular	  sinus	  macrophages	  retain	  control	  and	  pIC-­‐exosomes.	  	  
	  Figure	  S8:	  	  	  Validation	  of	  M1	  markers	  Cd86	  and	  MhcII	  expression	  in	  lymph	  node	  sections	  after	  exposure	  
to	  control	  or	  pIC	  exosomes.	  White	  scale	  bars,	  50	  μm,	  yellow	  scale	  bars,	  10	  μm.	  
	  Figure	  S9:	  Lymphatic	  transport	  and	  retention	  of	  exosomes.	  pIC	  exosomes	  are	  seen	  in	  the	  lymphatic	  
collecting	  vessels	  at	  (a)	  0	  mins,	  (b)	  1.5	  mins,	  (c)	  3	  mins,	  (d)	  5mins	  ,	  (e)	  15	  mins	  and	  (f)	  2	  days.	  The	  
injection	  site	  is	  shown	  at	  (g)	  20	  mins	  and	  (h)	  2	  days.	  	  Exosomes	  are	  detected	  in	  the	  draining	  lymph	  node	  
at	  (i)	  0	  mins,	  (j)	  2mins,	  (k)	  5	  mins	  and	  (l)	  15	  mins+	  
	  
	  
	  Figure	  S10:	  Kinetics	  of	  exosome	  transport	  in	  the	  lymphatics.	  (a)	  Arrival	  time	  of	  detectable	  levels	  of	  
fluorescence	  for	  collecting	  vessels	  and	  draining	  lymph	  nodes.	  (b)	  Packet	  frequency	  of	  control	  and	  pIC	  
exosomes	  in	  the	  collecting	  lymphatic	  vessels	  and	  nodes.	  
Video	  S1:	  Example	  video	  of	  pIC	  exosome	  arrival	  in	  the	  collecting	  vessels	  of	  a	  mouse	  10	  cm	  downstream	  
from	  the	  site	  of	  intradermal	  injection.	  The	  dominant	  vessel	  is	  seen	  below	  and	  the	  non-­‐dominant	  vessel	  
is	  seen	  above.	  Video	  is	  played	  at	  10X	  speed	  	  
Video	  S2:	  Example	  video	  of	  pIC	  exosome	  arrival	  in	  the	  draining	  (sciatic)	  lymph	  nodes	  of	  a	  mouse	  within	  
minutes	  of	  intradermal	  exosome	  injection	  at	  the	  tip	  of	  the	  tail.	  The	  dominant	  node	  is	  seen	  below	  and	  
the	  non-­‐dominant	  vessel	  is	  seen	  above.	  Video	  is	  played	  at	  10X	  speed	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